Form 4 for DMAC DiaMedica Therapeutics Inc.
Accepted 2024-07-01 00:00:00 ET · period of report 2024-06-28 · accession 0001104659-24-076840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-07-01 | 2024-06-28 | DMAC | STAHLBERG JAN | 10% | P - Purchase | $2.50 | +1.20M | 5.22M | +30% | +$3.00M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-06-28 | P | A | 1,200,000 | $2.50 | 5,221,608 | I See Footnote 1 | — | — | (F1) These shares are owned directly by Trill AB and indirectly by Jan Stahlberg in his capacity as the board member and sole owner of Trill AB. Jan Stahlberg has the sole power to vote and dispose of these shares. |